Afya Limited (NASDAQ:AFYA – Get Rating)’s share price dropped 8.7% on Tuesday after Credit Suisse Group lowered their price target on the stock from $19.00 to $18.00. Credit Suisse Group currently has an outperform rating on the stock. Afya traded as low as $14.31 and last traded at $14.41. Approximately 7,738 shares changed hands during trading, a decline of 98% from the average daily volume of 459,594 shares. The stock had previously closed at $15.79.
AFYA has been the topic of a number of other research reports. TheStreet upgraded Afya from a “d+” rating to a “c” rating in a research note on Friday, September 9th. The Goldman Sachs Group lifted their price target on Afya from $12.00 to $13.50 in a research note on Tuesday, September 6th.
Hedge Funds Weigh In On Afya
Institutional investors and hedge funds have recently modified their holdings of the business. TimesSquare Capital Management LLC increased its stake in Afya by 33.3% during the 1st quarter. TimesSquare Capital Management LLC now owns 1,200,100 shares of the company’s stock worth $17,293,000 after buying an additional 299,700 shares in the last quarter. GSA Capital Partners LLP acquired a new position in shares of Afya during the 1st quarter worth approximately $694,000. JPMorgan Chase & Co. acquired a new position in shares of Afya during the 1st quarter worth approximately $14,949,000. Jupiter Asset Management Ltd. boosted its holdings in shares of Afya by 13.2% during the 1st quarter. Jupiter Asset Management Ltd. now owns 369,959 shares of the company’s stock worth $5,331,000 after purchasing an additional 43,032 shares during the last quarter. Finally, Sycomore Asset Management acquired a new position in shares of Afya during the 1st quarter worth approximately $1,122,000. Hedge funds and other institutional investors own 60.45% of the company’s stock.
Afya Trading Down 8.0 %
The firm has a market capitalization of $1.34 billion, a price-to-earnings ratio of 22.56, a PEG ratio of 0.43 and a beta of 0.88. The company has a fifty day moving average price of $14.47 and a two-hundred day moving average price of $12.40. The company has a current ratio of 1.33, a quick ratio of 1.31 and a debt-to-equity ratio of 0.37.
Afya (NASDAQ:AFYA – Get Rating) last issued its earnings results on Monday, August 22nd. The company reported $0.24 earnings per share for the quarter, topping the consensus estimate of $0.20 by $0.04. The business had revenue of $121.93 million for the quarter, compared to analysts’ expectations of $119.45 million. Afya had a return on equity of 10.99% and a net margin of 15.67%. As a group, research analysts forecast that Afya Limited will post 0.97 earnings per share for the current fiscal year.
Afya Company Profile
Afya Ltd. is a medical education group, which engages in the provision of an end-to-end physician-centric ecosystem that serves and empowers students to be lifelong medical learners through their medical residency preparation, post-graduate programs, and continuing medical education activities. It operates through Education Services; and Digital Content, Residency Preparatory and Specialization Programs segments.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to email@example.com.
Before you consider Afya, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Afya wasn’t on the list.
While Afya currently has a “Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.